The combined effects of novel tocotrienols and lovastatin on lipid metabolism in chickens (Q43614828)

25 November 2017

title

The combined effects of novel tocotrienols and lovastatin on lipid metabolism in chickens (English)

1 reference

25 November 2017

A A Qureshi

1 reference

25 November 2017

D M Peterson

series ordinal

1 reference

25 November 2017

language of work or name

1 reference

1 May 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

156

1 reference

25 November 2017

1 reference

25 November 2017

page(s)

39-47

1 reference

gamma-Tocotrienol as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diets

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Regulation of the mevalonate pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Effect of atherogenic diet on chicken plasma lipids and lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Lipid Biosynthesis in the Chick. A Consideration of Site of Synthesis, Influence of Diet and Possible Regulatory Mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Comparative aspects of lipogenesis in mammalian tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Effect of AMO 1618 on cholesterol and fatty acid metabolism in chickens and rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Cholesterol and fatty acid synthesis in swine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Response of hypercholesterolemic subjects to administration of tocotrienols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Dietary alpha-tocopherol attenuates the impact of gamma-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

A receptor-mediated pathway for cholesterol homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Lipid-lowering drugs. An overview of indications and optimum therapeutic use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Dietary tocotrienols reduce concentrations of plasma cholesterol, apolipoprotein B, thromboxane B2, and platelet factor 4 in pigs with inherited hyperlipidemias.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Effects of gamma-tocotrienol on ApoB synthesis, degradation, and secretion in HepG2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Effect of garlic on carbohydrate metabolism and lipid synthesis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900612-2

10.1016/S0021-9150(00)00612-2

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference